{"id":"W2040437210","doi":"10.3899/jrheum.080734","title":"The Efficacy and Safety of Milnacipran for Treatment of Fibromyalgia. A Randomized, Double-blind, Placebo-controlled Trial","year":2009,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":248,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Milnacipran; Medicine; Fibromyalgia; Placebo; Adverse effect; Anesthesia; Randomized controlled trial; Visual analogue scale; Clinical endpoint; Internal medicine; Physical therapy; Serotonin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002369391,0.00114185,0.002589416,0.000433024,0.0004713887,0.0007831492,0.000832941,0.002203143,0.006032636],"category_scores_gemma":[0.002276719,0.0006199861,0.001183196,0.0003301187,0.001010158,0.0006698882,0.0002811186,0.001593372,0.0008589203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004253504,"about_ca_system_score_gemma":0.000902918,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000475018,"about_ca_topic_score_gemma":0.0008185157,"domain_scores_codex":[0.9989231,0.0006653827,0.00009700405,0.0001502375,0.00008499809,0.0000791733],"domain_scores_gemma":[0.9989213,0.0003888573,0.0003114921,0.00006643837,0.00007912115,0.0002328409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9834766,0.002931064,0.000268099,0.0007592918,0.0004527168,0.00002856596,0.00001822784,0.00007593616,0.002117543,0.00004419705,0.000291853,0.009535809],"study_design_scores_gemma":[0.9755971,0.02287562,0.0006807793,0.00002412914,0.0002348321,0.00001564784,0.000004603045,0.0001419783,0.0001854323,0.00002249169,0.0002130402,0.000004396058],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9730578,0.01440677,0.0008394856,0.001088551,0.0009588867,0.00603664,0.001055494,0.0002033974,0.002352966],"genre_scores_gemma":[0.9790345,0.00604993,0.002415504,0.001496943,0.001141942,0.006602158,0.0009611933,0.00002229745,0.002275573],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006032636,"threshold_uncertainty_score":0.02018124,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02919004012814288,"score_gpt":0.3290648000342665,"score_spread":0.2998747599061236,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}